0000914190-20-000341.txt : 20200824
0000914190-20-000341.hdr.sgml : 20200824
20200824172854
ACCESSION NUMBER: 0000914190-20-000341
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200820
FILED AS OF DATE: 20200824
DATE AS OF CHANGE: 20200824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Points Jeffrey S.
CENTRAL INDEX KEY: 0001731414
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52082
FILM NUMBER: 201128736
MAIL ADDRESS:
STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC.
STREET 2: 1225 OLD HIGHWAY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiovascular Systems Inc
CENTRAL INDEX KEY: 0001180145
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411698056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
BUSINESS PHONE: 651-259-1600
MAIL ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
FORMER COMPANY:
FORMER CONFORMED NAME: REPLIDYNE INC
DATE OF NAME CHANGE: 20020813
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-08-20
0001180145
Cardiovascular Systems Inc
CSII
0001731414
Points Jeffrey S.
1225 OLD HIGHWAY 8 NW
ST. PAUL
MN
55112
0
1
0
0
Chief Financial Officer
Common Stock
2020-08-20
4
D
0
837
0
D
83958
D
Common Stock
2020-08-20
4
F
0
981
32.77
D
82977
D
Represents shares of performance-based restricted stock granted in August 2017 that have been forfeited based on the Company's three year total shareholder return for fiscal years 2018, 2019 and 2020 versus the Company's peer group.
The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grant.
/s/ Amanda Lorentz as Attorney-in-Fact for Jeffrey S. Points pursuant to Power of Attorney previously filed.
2020-08-24